Isolation of rifampicin resistant Flavobacterium psychrophilum strains and their potential as live attenuated vaccine candidates

Vaccine

Volumn 26, Issue 44, 2008, Pages 5582-5589

  LaFrentz, Benjamin R ^a   LaPatra, Scott E ^b   Call, Douglas R ^c   Cain, Kenneth D ^a  

^a UNIVERSITY OF IDAHO   (United States)

^b CLEAR SPRINGS FOODS INC   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Flavobacterium psychrophilum; Live attenuated vaccine; Rainbow trout

Indexed keywords

LIVE VACCINE; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; ELECTROPHORESIS; FLAVOBACTERIUM; FLAVOBACTERIUM PSYCHROPHILUM; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAINBOW TROUT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; DRUG RESISTANCE, BACTERIAL; FISH DISEASES; FLAVOBACTERIACEAE INFECTIONS; FLAVOBACTERIUM; IMMUNIZATION; ONCORHYNCHUS MYKISS; RIFAMPIN; VACCINES, ATTENUATED; VIRULENCE;

EID: 52949126405     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.083     Document Type: Article

References (72)

1. Michel C., Antonio D., and Hedrick R.P. Production of viable cultures of Flavobacterium psychrophilum: approach and control. Res Microbiol 150 5 (1999) 351-358
2. Rahman M.H., Ototake M., Lida Y., Yokomizo Y., and Nakanishi T. Efficacy of oil-adjuvanted vaccine for coldwater disease in ayu Plecoglossus altivelis. Fish Pathol 35 4 (2000) 199-203
3. Holt R.A. Cytophaga psychrophila, the causative agent of bacterial cold-water disease in salmonid fish [dissertation] (1988), Oregon State University, Corvallis
4. Obach A., and Laurencin F.B. Vaccination of rainbow trout Oncorhynchus mykiss against the visceral form of coldwater disease. Dis Aquat Org 12 1 (1991) 13-15
5. LaFrentz B.R., LaPatra S.E., Jones G.R., Congleton J.L., Sun B., and Cain K.D. Characterization of serum and mucosal antibody responses and relative per cent survival in rainbow trout, Oncorhynchus mykiss (Walbaum), following immunization and challenge with Flavobacterium psychrophilum. J Fish Dis 25 12 (2002) 703-713
6. Kondo M., Kawai K., Okabe M., Nakano N., and Oshima S. Efficacy of oral vaccine against bacterial coldwater disease in ayu Plecoglossus altivelis. Dis Aquat Org 55 3 (2003) 261-264
7. Rahman M.H., Ototake M., and Nakanishi T. Water-soluble adjuvants enhance the protective effect of Flavobacterium psychrophilum vaccines in ayu Plecoglossus altivelis. Fish Pathol 38 4 (2003) 171-176
8. Madetoja J., Lonnstrom L.G., Bjorkblom C., Ulukoy G., Bylund G., Syvertsen C., et al. Efficacy of injection vaccines against Flavobacterium psychrophilum in rainbow trout Oncorhynchus mykiss (Walbaum). J Fish Dis 29 1 (2006) 9-20
9. Aoki M., Kondo M., Nakatsuka Y., Kawai K., and Oshima S. Stationary phase culture supernatant containing membrane vesicles induced immunity to rainbow trout Oncorhynchus mykiss fry syndrome. Vaccine 25 3 (2007) 561-569
10. Rahman M.H., Kuroda A., Dijkstra J.M., Kiryu I., Nakanishi T., and Ototake M. The outer membrane fraction of Flavobacterium psychrophilum induces protective immunity in rainbow trout and ayu. Fish Shellfish Immunol 12 2 (2002) 169-179
11. LaFrentz B.R., LaPatra S.E., Jones G.R., and Cain K.D. Protective immunity in rainbow trout Oncorhynchus mykiss following immunization with distinct molecular mass fractions isolated from Flavobacterium psychrophilum. Dis Aquat Org 59 1 (2004) 17-26
12. Dumetz F., Duchaud E., LaPatra S.E., Le Marrec C., Claverol S., Urdaci M.C., et al. A protective immune response is generated in rainbow trout by an OmpH-like surface antigen (P18) of Flavobacterium psychrophilum. Appl Environ Microbiol 72 7 (2006) 4845-4852
13. Dumetz F., Lapatra S.E., Duchaud E., Claverol S., and Le Henaff M. The Flavobacterium psychrophilum OmpA, an outer membrane glycoprotein, induces a humoral response in rainbow trout. J Appl Microbiol 103 5 (2007) 1461-1470
14. Crump E.M., Burian J., Allen P.D., Gale S., and Kay W.W. Identification of a ribosomal L10-like protein from Flavobacterium psychrophilum as a recombinant vaccine candidate for rainbow trout fry syndrome. J Mol Microbiol Biotechnol 13 1-3 (2007) 55-64
15. Crump E.M., Burian J., Allen P.D., and Kay W.W. Identification and expression of a host-recognized antigen, FspA, from Flavobacterium psychrophilum. Microbiology 151 9 (2005) 3127-3135
16. Temprano A., Riano J., Yugueros J., Gonzalez P., de Castro L., Villena A., et al. Potential use of a Yersinia ruckeri O1 auxotrophic aroA mutant as a live attenuated vaccine. J Fish Dis 28 7 (2005) 419-427
17. Lan M.Z., Peng X., Xiang M.Y., Xia Z.Y., Bo W., Jie L., et al. Construction and characterization of a live, attenuated esrB mutant of Edwardsiella tarda and its potential as a vaccine against the haemorrhagic septicaemia in turbot Scophthamus maximus (L.). Fish Shellfish Immunol 23 3 (2007) 521-530
18. Klesius P.H., and Shoemaker C.A. Development and use of modified live Edwardsiella ictaluri vaccine against enteric septicemia of catfish. Adv Vet Med 41 (1999) 523-537
19. Lawrence M.L., and Banes M.M. Tissue persistence and vaccine efficacy of an O polysaccharide mutant strain of Edwardsiella ictaluri. J Aquat Anim Health 17 3 (2005) 228-232
20. Lawrence M.L., Cooper R.K., and Thune R.L. Attenuation, persistence, and vaccine potential of an Edwardsiella ictaluri purA mutant. Infect Immun 65 11 (1997) 4642-4651
21. Thune R.L., Fernandez D.H., and Battista J.R. An aroA mutant of Edwardsiella ictaluri is safe and efficacious as a live, attenuated vaccine. J Aquat Anim Health 11 4 (1999) 358-372
22. Liu Y., and Bi Z. Potential use of a transposon Tn916-generated mutant of Aeromonas hydrophila J-1 defective in some exoproducts as a live attenuated vaccine. Prev Vet Med 78 1 (2007) 79-84
23. Moral C.H., Castillo EFd, Fierro P.L., Cortes A.V., Castillo J.A., Soriano A.C., et al. Molecular characterization of the Aeromonas hydrophila aroA gene and potential use of an auxotrophic aroA mutant as a live attenuated vaccine. Infect Immun 66 5 (1998) 1813-1821
24. Thornton J.C., Garduno R.A., and Kay W.W. The development of live vaccines for furunculosis lacking the A-layer and O-antigen of Aeromonas salmonicida. J Fish Dis 17 3 (1994) 195-204
25. Vaughan L.M., Smith P.R., and Foster T.J. An aromatic-dependent mutant of the fish pathogen Aeromonas salmonicida is attenuated in fish and is effective as a live vaccine against the salmonid disease furunculosis. Infect Immun 61 5 (1993) 2172-2181
26. Buchanan J.T., Stannard J.A., Lauth X., Ostland V.E., Powell H.C., Westerman M.E., et al. Streptococcus iniae phosphoglucomutase is a virulence factor and a target for vaccine development. Infect Immun 73 10 (2005) 6935-6944
27. Norqvist A., Hagstrom A., and Wolf-Watz H. Protection of rainbow trout against vibriosis and furunculosis by the use of attenuated strains of Vibrio anguillarum. Appl Environ Microbiol 55 6 (1989) 1400-1405
28. Shoemaker C.A., Klesius P.H., and Evans J.J. Immunization of eyed channel catfish, Ictalurus punctatus, eggs with monovalent Flavobacterium columnare vaccine and bivalent F. columnare and Edwardsiella ictaluri vaccine. Vaccine 25 6 (2007) 1126-1131
29. Daly J.G., Griffiths S.G., Kew A.K., Moore A.R., and Olivier G. Characterization of attenuated Renibacterium salmoninarum strains and their use as live vaccines. Dis Aquat Org 44 2 (2001) 121-126
30. Alvarez B., Alvarez J., Menendez A., and Guijarro J.A. A mutant in one of two exbD loci of a TonB system in Flavobacterium psychrophilum shows attenuated virulence and confers protection against cold water disease. Microbiology 154 4 (2008) 1144-1151
31. Lawrence M.L., Banes M.M., and Williams M.L. Phenotype and virulence of a transposon-derived lipopolysaccharide O side-chain mutant strain of Edwardsiella ictaluri. J Aquat Anim Health 13 4 (2001) 291-299
32. Bader J.A., Shoemaker C.A., and Klesius P.H. Production, characterization and evaluation of virulence of an adhesion defective mutant of Flavobacterium columnare produced by β-lactam selection. Lett Appl Microbiol 40 2 (2005) 123-127
33. Wehrli W., Knusel F., Schmid K., and Staehelin M. Interaction of rifamycin with bacterial RNA polymerase. Proc Natl Acad Sci USA 61 2 (1968) 667-673
34. Bhatnagar N., Getachew E., Straley S., Williams J., Meltzer M., and Fortier A. Reduced virulence of rifampicin-resistant mutants of Francisella tularensis. J Infect Dis 170 4 (1994) 841-847
35. Manten A., and Van Wijngaarden L.J. Development of drug resistance to rifampicin. Chemotherapy 14 2 (1969) 93-100
36. Moorman D.R., and Mandell G.L. Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 20 6 (1981) 709-713
37. Schurig G.G., Roop II R.M., Bagchi T., Boyle S., Buhrman D., and Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol 28 2 (1991) 171-188
38. Sudheesh P.S., LaFrentz B.R., Call D.R., Siems W.F., LaPatra S.E., Wiens G.D., et al. Identification of potential vaccine target antigens by immunoproteomic analysis of a virulent and a non-virulent strain of the fish pathogen Flavobacterium psychrophilum. Dis Aquat Org 74 1 (2007) 37-47
39. Holt R.A., Rohovec J.S., and Fryer J.L. Bacterial coldwater disease. In: Inglis V., Roberts R.J., and Bromage N.R. (Eds). Bacterial diseases of fish (1993), Blackwell Scientific Publications, Oxford 3-23
40. Chen C.Y., Nace G.W., and Irwin P.L. A 6 × 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli. J Microbiol Methods 55 2 (2003) 475-479
41. Hitchcock P.J., and Brown T.M. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol 154 1 (1983) 269-277
42. LaFrentz B.R., Lindstrom N.M., LaPatra S.E., Call D.R., and Cain K.D. Electrophoretic and Western blot analyses of the lipopolysaccharide and glycocalyx of Flavobacterium psychrophilum. Fish Shellfish Immunol 23 4 (2007) 770-780
43. LaFrentz B.R., LaPatra S.E., Jones G.R., and Cain K.D. Passive immunization of rainbow trout, Oncorhynchus mykiss (Walbaum), against Flavobacterium psychrophilum, the causative agent of bacterial coldwater disease and rainbow trout fry syndrome. J Fish Dis 26 7 (2003) 371-384
44. Amend D.F. Potency testing of fish vaccines. Dev Biol Stand 49 (1981) 447-454
45. Zar J.H. Biostatistical analysis. 3rd ed. (1996), Prentice-Hall, London
46. Jin D.J., and Gross C.A. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol 202 1 (1988) 45-58
47. Marianelli C., Ciuchini F., Tarantino M., Pasquali P., and Adone R. Genetic bases of the rifampin resistance phenotype in Brucella spp. J Clin Microbiol 42 12 (2004) 5439-5443
48. Taniguchi H., Aramaki H., Nikaido Y., Mizuguchi Y., Nakamura M., Koga T., et al. Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett 144 1 (1996) 103-108
49. Maughan H., Galeano B., and Nicholson W.L. Novel rpoB mutations conferring rifampin resistance on Bacillus subtilis: global effects on growth, competence, sporulation, and germination. J Bacteriol 186 8 (2004) 2481-2486
50. Billington O.J., McHugh T.D., and Gillespie S.H. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 43 8 (1999) 1866-1869
51. Mariam D.H., Mengistu Y., Hoffner S.E., and Andersson D.I. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob Agents Chemother 48 4 (2004) 1289-1294
52. Reynolds M.G. Compensatory evolution in rifampin-resistant Escherichia coli. Genetics 156 4 (2000) 1471-1481
53. Jin D.J., and Gross C.A. Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli. J Bacteriol 171 9 (1989) 5229-5231
54. Neuhard J., Jensen K.F., and Stauning E. Salmonella typhimurium mutants with altered expression of the pyrA gene due to changes in RNA polymerase. EMBO J 1 9 (1982) 1141-1145
55. Schwarz T.F., Yeats S.M., Connolly P., and McConnell D.J. Altered transcriptional termination in a rifampicin-resistant mutant of Escherichia coli which inhibits the growth of bacteriophage T7. Mol Gen Genet 183 1 (1981) 181-186
56. Zhang Y., Arias C.R., Shoemaker C.A., and Klesius P.H. Comparison of lipopolysaccharide and protein profiles between Flavobacterium columnare strains from different genomovars. J Fish Dis 29 11 (2006) 657-663
57. Cloeckaert A., Zygmunt M.S., and Guilloteau L.A. Brucella abortus vaccine strain RB51 produces low levels of M-like O-antigen. Vaccine 20 13-14 (2002) 1820-1822
58. Vemulapalli R., McQuiston J.R., Schurig G.G., Sriranganathan N., Halling S.M., and Boyle S.M. Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains. Clin Diagn Lab Immunol 6 5 (1999) 760-764
59. Vemulapalli R., He Y., Buccolo L.S., Boyle S.M., Sriranganathan N., and Schurig G.G. Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation. Infect Immun 68 7 (2000) 3927-3932
60. Arias C.R., Shoemaker C.A., Evans J.J., and Klesius P.H. A comparative study of Edwardsiella ictaluri parent (EILO) and E. ictaluri rifampicin-mutant (RE-33) isolates using lipopolysaccharides, outer membrane proteins, fatty acids, Biolog API 20E and genomic analyses. J Fish Dis 26 7 (2003) 415-421
61. Allen C.A., Adams L.G., and Ficht T.A. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival. Infect Immun 66 3 (1998) 1008-1016
62. Shoemaker C.A., Klesius P.H., and Bricker J.M. Efficacy of a modified live Edwardsiella ictaluri vaccine in channel catfish as young as seven days post hatch. Aquaculture 176 3-4 (1999) 189-193
63. Shoemaker C.A., Klesius P.H., and Evans J.J. In ovo methods for utilizing the modified live Edwardsiella ictaluri vaccine against enteric septicemia in channel catfish. Aquaculture 203 3-4 (2002) 221-227
64. Garcia C., Pozet F., and Michel C. Standardization of experimental infection with Flavobacterium psychrophilum, the agent of rainbow trout Oncorhynchus mykiss fry syndrome. Dis Aquat Org 42 3 (2000) 191-197
65. Decostere A., Lammens M., and Haesebrouck F. Difficulties in experimental infection studies with Flavobacterium psychrophilum in rainbow trout (Oncorhynchus mykiss) using immersion, oral and anal challenges. Res Vet Sci 69 2 (2000) 165-169
66. Borg A.F. Studies on myxobacteria associated with diseases in salmonid fishes [dissertation] (1948), University of Washington, Seattle
67. Madetoja J., Nyman P., and Wiklund T. Flavobacterium psychrophilum, invasion into and shedding by rainbow trout Oncorhynchus mykiss. Dis Aquat Org 43 1 (2000) 27-38
68. Madsen L., and Dalsgaard I. Reproducible methods for experimental infection with Flavobacterium psychrophilum in rainbow trout Oncorhynchus mykiss. Dis Aquat Org 36 3 (1999) 169-176
69. Wiklund T., and Dalsgaard I. Survival of Flavobacterium psychrophilum in rainbow trout (Oncorhynchus mykiss) serum in vitro. Fish Shellfish Immunol 12 2 (2002) 141-153
70. Marsden M.J., Vaughan L.M., Fitzpatrick R.M., Foster T.J., and Secombes C.J. Potency testing of a live, genetically attenuated vaccine for salmonids. Vaccine 16 11-12 (1998) 1087-1094
71. Marsden M.J., Vaughan L.M., Foster T.J., and Secombes C.J. A live (delta aroA) Aeromonas salmonicida vaccine for furunculosis preferentially stimulates T-cell responses relative to B-cell responses in rainbow trout (Oncorhynchus mykiss). Infect Immun 64 9 (1996) 3863-3869
72. Vivas J., Riano J., Carracedo B., Razquin B.E., Lopez-Fierro P., Naharro G., et al. The auxotrophic aroA mutant of Aeromonas hydrophila as a live attenuated vaccine against A. salmonicida infections in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol 16 2 (2004) 193-206